CYT997(917111-44-5)
- Name: CYT997
- Synonyms:(S)-1-ethyl-3-(2-methoxy-4-(5-methyl-4-((1-(pyridin-3-yl)butyl)amino)pyrimidin-2-yl)phenyl)urea;Lexibulin (USAN);S2195_Selleck;LEXIBULIN;Lexibulin;N-[2-methoxy-4-(6-{[(1S)-1-pyridin-3-ylbutyl]amino}pyrazin-2-yl)phenyl]-N'-ethylurea;CYT997 (Lexibulin);Lexibulin [USAN:INN];N-ethyl-N'-[2-methoxy-4-(5-methyl-4-{[(1S)-1-pyridin-3-ylbutyl]amino}pyrimidin-2-yl)phenyl]urea;Lexibulin [INN];CYT997;查看更多英文别名
- Molecular Formula:C24H30N6O2
- Molecular Weight:434.541
- CAS Registry Number:917111-44-5
- EINECS:604-604-1
- Melting Point:
- Water Solubility:

Other Product
- 880090-88-0/Neuropathiazol
- 935693-62-2/BIX 01294, 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine hydrate trihydrochloride
- 129830-38-2/Y27632 (hydrochloride)
- 925434-55-5/N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide
- 937265-83-3/ARRY-380
- 845272-21-1/ARRY-334543
- 957890-42-5/6-Chloro-2-methyl-4-phenyl-alpha-propyl-3-quinolineacetic acid
- 356057-34-6/Darapladib
- 522629-08-9/CGP 57380
- 445430-58-0/IKK Inhibitor III, BMS-345541
- 547757-23-3/BMS-345541
- 487021-52-3/AR-A014418
- 1003216-79-2/Benzamide, 2-[(2-chloro-4-iodophenyl)amino]-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-
- 1003216-77-0/Benzamide, 2-[(2-chloro-4-iodophenyl)amino]-N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-
- 566939-85-3/6-[(7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide
- 752243-39-3/6-[7(R)-Hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide
- 452105-23-6/1H-Pyrrole-3-carboxaMide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-N-[(2S)-2-hydroxy-3-(4-Morpholinyl)propyl]-2,4-diMethyl-
- 1003580-86-6/S3I-M2001
- 892546-37-1/PH-064
- 917111-44-5/CYT997
- 1174046-72-0/BMS-794833
- 913822-46-5/4-Thiazolecarboxamide, N-(6-benzoyl-1H-benzimidazol-2-yl)-2-(1-thieno[3,2-d]pyrimidin-4-yl-4-piperidinyl)-
- 1228839-23-3/[1,1'-Biphenyl]-4-carboxylic acid, 2'-[(1R)-1-[(2R)-3-[[2-[3-fluoro-4-(methylthio)phenyl]-1,1-dimethylethyl]amino]-2-hydroxypropoxy]ethyl]-3-methyl-
- 1227827-93-1/2,4-Oxazolidinedione, 5-[6-(8-fluoro-2-naphthalenyl)-1,2-dihydro-2-oxo-3-pyridinyl]-5-(1-methylethyl)-
- 1004316-88-4/Cobicistat
- 779353-01-4/(2S)-1-[3-Ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol
- 1219700-72-7/8-Isoquinolinecarboxamide, N-[4-chloro-3-(trifluoromethyl)phenyl]-1,2,3,4,4a,7,8,8a-octahydro-1-oxo-2-(phenylmethyl)-, (4aR,8S,8aR)-
- 1128103-37-6/2(1H)-Pyridinone, 5-(difluoromethyl)-1-[(1S)-1-(4-fluorophenyl)ethyl]-3-[[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]amino]-
- 860638-96-6/2H-1,2,4-Benzothiadiazine, 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-, 1,1-dioxide
- 1174207-12-5/4H-Quinolizine-3-carboxylic acid, 1-[[4-(4-cyanophenyl)-1-piperazinyl]methyl]-4-oxo-